Mesenchymal Stem Cells Modified with Stromal Cell-Derived Factor 1α Improve Cardiac Remodeling via Paracrine Activation of Hepatocyte Growth Factor in a Rat Model of Myocardial Infarction

Aoki, 2000, Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium, up-regulation of essential transcription factor for angiogenesis, ets, Gene Ther, 7, 417, 10.1038/sj.gt.3301104

Barkho, 2008, Endogenous matrix metalloproteinase (MMP)-3 and MMP-9 promote the differentiation and migration of adult neural progenitor cells in response to chemokines, Stem Cells, 26, 3139, 10.1634/stemcells.2008-0519

Chen, 2008, Stromal cell-derived factor-1 promotes bone marrow-derived cells differentiation to cardiomyocyte phenotypes in vitro, Cell Prolif, 41, 336, 10.1111/j.1365-2184.2008.00519.x

Elmadbouh, 2007, Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium, J. Mol. Cell Cardiol, 42, 792, 10.1016/j.yjmcc.2007.02.001

Fedak, 2008, Paracrine effects of cell transplantation, modifying ventricular remodeling in the failing heart, Semin. Thorac. Cardiovasc. Surg, 20, 87, 10.1053/j.semtcvs.2008.04.001

Gnecchi, 2006, Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement, Faseb J, 20, 661, 10.1096/fj.05-5211com

Guo, 2007, Antiinflammation role for mesenchymal stem cells transplantation in myocardial infarction, Inflammation, 30, 97, 10.1007/s10753-007-9025-3

Hiasa, 2004, Circulation, 109, 2454, 10.1161/01.CIR.0000128213.96779.61

Higashiyama, 2007, Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice, Hepatology, 45, 213, 10.1002/hep.21477

Hu, 2008, Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis, J. Thorac. Cardiovasc. Surg, 135, 799, 10.1016/j.jtcvs.2007.07.071

Inagaki, 2007, Treatment strategy for liver fibrosis through recruitment and differentiation of bone marrow stem/progenitor cells, Hepatol. Res, 37, 991, 10.1111/j.1872-034X.2007.00267.x

Janowska-Wieczorek, 2000, Differential MMP and TIMP production by human marrow and peripheral blood CD34(+) cells in response to chemokines, Exp. Hematol, 28, 1274, 10.1016/S0301-472X(00)00532-4

Kinnaird, 2004, Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms, Circ. Res, 94, 678, 10.1161/01.RES.0000118601.37875.AC

Koch, 2006, Effect of catheter-based transendocardial delivery of stromal cell-derived factor 1alpha on left ventricular function and perfusion in a porcine model of myocardial infarction, Basic Res. Cardiol, 101, 69, 10.1007/s00395-005-0570-3

Kollet, 2003, HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver, J. Clin. Invest, 112, 160, 10.1172/JCI17902

Kortesidis, 2005, Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells, Blood, 105, 3793, 10.1182/blood-2004-11-4349

Li, 2001, Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury, Ann. Thorac. Surg, 72, 1957, 10.1016/S0003-4975(01)03216-7

Li, 2008, Mesenchymal stem cell transplantation attenuates cardiac fibrosis associated with isoproterenol-induced global heart failure, Transpl. Int, 21, 1181, 10.1111/j.1432-2277.2008.00742.x

Li, 2008, Bcl-2 engineered MSCs inhibited apoptosis and improved heart function, Stem Cells, 25, 2118, 10.1634/stemcells.2006-0771

Liu, 2008, Therapeutic potential of angiogenin modified mesenchymal stem cells, angiogenin improves mesenchymal stem cells survival under hypoxia and enhances vasculogenesis in myocardial infarction, Microvasc. Res, 76, 23, 10.1016/j.mvr.2008.02.005

Mangi, 2003, Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts, Nat. Med, 9, 1195, 10.1038/nm912

Miyagawa, 2006, Angiogenic gene cell therapy using suicide gene system regulates the effect of angiogenesis in infarcted rat heart, Transplantation, 81, 902, 10.1097/01.tp.0000202843.86864.10

Morita, 2006, Selective matrix metalloproteinase inhibition attenuates progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure, Am. J. Physiol. Heart Circ. Physiol, 290, H2522, 10.1152/ajpheart.00932.2005

Nakamura, 2000, Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF, J. Clin. Invest, 106, 1511, 10.1172/JCI10226

Novotny, 2008, Stem cell therapy in myocardial repair and remodeling, J. Am. Coll. Surg, 207, 423, 10.1016/j.jamcollsurg.2008.04.013

Ohnishi, 2007, Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions, FEBS Lett, 581, 3961, 10.1016/j.febslet.2007.07.028

Pasha, 2008, Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium, Cardiovasc. Res, 77, 134, 10.1093/cvr/cvm025

Petit, 2005, Atypical PKC-zeta regulates SDF-1-mediated migration and development of human CD34+ progenitor cells, J. Clin. Invest, 115, 168, 10.1172/JCI200521773

Pittenger, 1999, Multilineage potential of adult human mesenchymal stem cells, Science, 284, 143, 10.1126/science.284.5411.143

Pons, 2008, VEGF improves survival of mesenchymal stem cells in infarcted hearts, Biochem. Biophys. Res. Commun, 376, 419, 10.1016/j.bbrc.2008.09.003

Reinhardt, 2002, Cardiac remodelling in end stage heart failure, upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP, Heart, 88, 525, 10.1136/heart.88.5.525

Ruiz de Almodovar, 2006, An SDF-1 trap for myeloid cells stimulates angiogenesis, Cell, 124, 18, 10.1016/j.cell.2005.12.023

Saxena, 2008, Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction, Circulation, 117, 2224, 10.1161/CIRCULATIONAHA.107.694992

Schober, 2006, SDF-1alpha-mediated tissue repair by stem cells, a promising tool in cardiovascular medicine? Trends Cardiovasc, Med, 16, 103

Schuh, 2008, Transplantation of endothelial progenitor cells improves neovascularization and left ventricular function after myocardial infarction in a rat model, Basic Res. Cardiol, 103, 69, 10.1007/s00395-007-0685-9

Schuleri, 2007, Mesenchymal stem cells for cardiac regenerative therapy, Handb. Exp. Pharmacol, 180, 195, 10.1007/978-3-540-68976-8_9

Shao, 2008, Statin and stromal cell derived factor-1 additively promote angiogenesis by enhancement of progenitor cells incorporation into new vessels, Stem Cells, 26, 1376, 10.1634/stemcells.2007-0785

Son, 2006, Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases, Stem Cells, 24, 1254, 10.1634/stemcells.2005-0271

Sun, 2007, Mesenchymal stem cells modified with angiopoietin-1 improve remodeling in a rat model of acute myocardial infarction, Biochem. Biophys. Res. Commun, 357, 779, 10.1016/j.bbrc.2007.04.010

Tang, 2006, Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion, Eur. J. Cardiothorac. Surg, 30, 353, 10.1016/j.ejcts.2006.02.070

Tang, 2008, Adenovirus-mediated stromal cell-derived-factor-1alpha gene transfer induces cardiac preservation after infarction via angiogenesis of CD133+ stem cells and anti-apoptosis, Interact. Cardiovasc. Thorac. Surg, 7, 767, 10.1510/icvts.2007.169896

Tang, 2009, Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats, Eur. J. Cardiothorac. Surg, 36, 644, 10.1016/j.ejcts.2009.04.052

Tang, 2009, Adenovirus-mediated stromal cell-derived factor-1 alpha gene transfer improves cardiac structure and function after experimental myocardial infarction through angiogenic and antifibrotic actions, Mol. Biol. Rep. [10.1007/ s11033-009-9642-z]

Taniyama, 2002, Angiogenesis and antifibrotic action by hepatocyte growth factor in cardiomyopathy, Hypertension, 40, 47, 10.1161/01.HYP.0000020755.56955.BF

Ueda, 2001, A potential cardioprotective role of hepatocyte growth factor in myocardial infarction in rats, Cardiovasc. Res, 51, 41, 10.1016/S0008-6363(01)00272-3

Wang, 2004, Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis, J. Mol. Cell. Cardiol, 37, 1041, 10.1016/j.yjmcc.2004.09.004

Xu, 2005, Effects of mesenchymal stem cell transplantation on extracellular matrix after myocardial infarction in rats, Coron. Artery Dis, 16, 245, 10.1097/00019501-200506000-00006

Yamaguchi, 2003, Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization, Circulation, 107, 1322, 10.1161/01.CIR.0000055313.77510.22

Yang, 2006, Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via non-infarct-relative artery in acute myocardial infarction, Gene Ther, 13, 1564, 10.1038/sj.gt.3302820

Zhang, 2007, SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction, Faseb J, 21, 3197, 10.1096/fj.06-6558com